Severe Systemic Envenomation Following Vipera berus Bite Managed with ViperaTAb Antivenom.
Wilderness & environmental medicine · 2018-10-29 · Case report
Abstract
Bites by the European adder (Vipera berus) are a rare medical emergency in the UK with 20 to 50% of an estimated 50 to 200 cases per year necessitating treatment with antivenom. We present a case demonstrating both severe systemic and local effects necessitating out of hospital resuscitation, vasopressor support, and prolonged rehabilitation. Hemodynamic stability was restored promptly after administration of ViperaTAb antivenom, the first published case of its use in the UK.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Cardiovascular drugs · Antivenom · Vasopressors · Antidotes · Rural & remote
Related articles
- Using geographical information systems to identify populations in need of improved accessibility to antivenom treatment for snakebite envenoming in Costa Rica. (PLoS Negl Trop Dis, 2013)
- Antivenom efficacy and traditional practices for Snakebite in Brazil: Where do they meet? (Toxicon, 2026)
- [Poisonous snake bites: prevention--first aid--clinical management]. (Ther Umsch, 2001)
- Administration of CroFab Antivenom by a Helicopter Emergency Medical Service Team. (Air Med J, 2016)
- Digital Health Intervention in Snakebite Management: Scoping Review. (J Med Internet Res, 2025)
- Snakebite epidemiology and health-seeking behavior in Akonolinga health district, Cameroon: Cross-sectional study. (PLoS Negl Trop Dis, 2020)